Knee Treatment with SVM

(N = 42)

Hub Treatment with SVM

(N = 7)

Age (mean ± standard deviation);

42.5 ± 5.4 (20 - 65)

53.5 ± 4.6 (42 - 65)

Body mass index

23.0 ± 2.2 (19.0 - 28.4)

25.0 ± 1.9 (21.0 - 29.2)

SVF Cell Density (×10⁶)

20.4 ± 1.2

10.2 ± 1.3

SVF Injection Volume (ml)

2 ± 0.2

1± 0.1

SVF Cell Viability (%)

94.1 ± 0.3

94.1 ± 0.4

Kallgren-Lawrence Grade, n

Grade II

20 ± 1.2

2 ± 0.5

Grade III

16 ± 1.4

5 ± 0.7

Grade IV

6 ± 0.8

-